Methods and compositions for treating congestive heart failure

Details for Australian Patent Application No. 2011235932 (hide)

Owner Theregen, Inc.

Inventors Naughton, Gail K.; Williams, Stuart K.; Kellar, Robert S.; Siani-Rose, Michael

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011235932

Parent 2005306270

Filing date 10 October 2011

Wipo publication date 3 November 2011

International Classifications

A61L 27/38 (2006.01) Materials for prostheses or for coating prostheses

C12N 5/071 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Vertebrate cells or tissues, e.g. human cells or tissues

Event Publications

27 October 2011 Complete Application Filed

3 November 2011 Application Open to Public Inspection

  Published as AU-A-2011235932

24 November 2011 Amendment Made

  The nature of the amendment is: Amend the invention title to read Use of cultured three-dimensional tissue for treating congestive heart failure

27 September 2012 Alteration of Name

  The name of the applicant has been altered to The Arizona Board of Regents for The University of Arizona; Theregen, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011235933-Antimicrobial peptides comprising an arginineand/or lysine-containing motif

2011235931-A gaming system and a method of gaming